Information for:

Future student
Alumni
Organisations
  • Masters
  • Postgrad courses
  • Courses
  • Faculty and research
  • About UPF-BSM

Information for:

Future student
Alumni
Organisations
E-Campus
E-Secretaria

Josep Lluis Segú Tolsa

Part-time Lecturer UPF-BSM

Lluís Segú is Professor in the Master of Health Economics and Pharmacoeconomics at UPF-BSM.

He is BSc in Pharmacy from the University of Barcelona, Diploma in Health, International Public Health from Carlos III University of Madrid, and Master in Economic Evaluation and Management of Health Services from the University of Barcelona. Managing Partner of Oblikue Consulting SL, he is also Associate Professor of the Clinical Pharmacy Unit of the Department of Galenic Pharmacy and Pharmaceutical Technology of the Faculty of Pharmacy of the University of Barcelona, and Collaborator of the Center for Research in Economics and Health (CRES). He has held...

  • Operations, Technology & Science

Professor

  • Online Master in Health Economics and Pharmacoeconomics
  • Online Master in Health Economics and Pharmacoeconomics

Actividad Investigadora y transferencia

  • PUIG JUNOY, J., CAMPILLO ARTERO, C., SEGÚ TOLSA, J. L., TRAPERO BERTRAN, M. (2020). Price Models for Multi-indication Drugs: A Systematic Review. Applied Health Economics and Health Policy, Nueva Zelanda.
  • CAMPILLO ARTERO, C., PUIG JUNOY, J., SEGÚ TOLSA, J. L., TRAPERO-BERTRAN, M. (2019). Price Models for Multi-indication Drugs: A Systematic Review. Applied Health Economics and Health Policy.
  • COSTA, K. S., GOLDBAUM, M., GUAYTA-ESCOLIES, R., MODAMIO, P., MARIÑO, E. L., SEGÚ TOLSA, J. L. (2017). Coordinación entre servicios farmacéuticos para una farmacoterapia integrada: el caso de Cataluña. Ciência & Saúde Coectiva.
  • LÓPEZ-MARTÍNEZ, N., SEGÚ TOLSA, J. L., VÁZQUEZ-CASTRO, J., BROSA, M., BOHIGAS, L., COMELLAS, M. J., KALFHAUS, L. (2017). Analysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support. Expert Review of Pharmacoeconomics & Outcomes Research.
  • CLOPES, A., GASOL, M., CAJAL, R., SEGÚ TOLSA, J. L., CRESPO, R., MORA, R., ... GERMÀ, J. R. (2017). Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer. Journal of Medical Economics.
  • SEGÚ TOLSA, J. L. (2016). ¿Qué servicios puede aportar la farmacia comunitaria al paciente crónico? Opinión de los profesionales. Pharmaceutical Care España, España.
  • SEGÚ TOLSA, J. L. (2016). Acceso a los anticoagulantes de acción directa en España. Revista Española de Cardiología.